The association between spouse-reported Type A behaviour pattern and coronary heart disease

M Atchison1, J Condon

  • 1Queen Elizabeth Hospital, Woodville, South Australia.

Insights

The Spouse-Report Type A Behaviour Pattern Questionnaire effectively identifies Type A behavior in cardiac patients. This validated tool shows a link between anger/hostility and coronary heart disease, but not disease severity.

Area of Science:

  • Psychological Medicine
  • Cardiology
  • Behavioral Science

Background:

  • Type A behavior pattern is associated with cardiovascular disease.
  • Validated instruments are needed to assess Type A behavior in clinical populations.
  • Previous research suggests a link between Type A traits and heart disease.

Purpose of the Study:

  • To further validate the Spouse-Report Type A Behaviour Pattern Questionnaire.
  • To assess the questionnaire's ability to discriminate between cardiac patients and healthy controls.
  • To explore the relationship between Type A scores and coronary heart disease severity.

Main Methods:

  • A case-controlled study design was employed.
  • 61 cardiac patients and 61 community controls participated.
  • The Spouse-Report Type A Behaviour Pattern Questionnaire was administered.

Main Results:

  • The questionnaire demonstrated statistical discrimination between cardiac patients and controls on the anger/hostility subscale and total Type A score.
  • No significant relationship was found between Type A score and coronary heart disease severity.
  • The findings support the questionnaire's utility in identifying Type A behavior relevant to cardiac health.

Conclusions:

  • The Spouse-Report Type A Behaviour Pattern Questionnaire is a valid tool for assessing Type A behavior in individuals with coronary heart disease.
  • Anger/hostility, a component of Type A behavior, is statistically associated with coronary heart disease.
  • Further research is needed to understand the complex relationship between Type A behavior patterns and cardiovascular disease progression.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
629
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
770
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
615